Serge Thal
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of Different SARS-CoV-2 Vaccine Schedules and Vaccination Intervals on Reactogenicity and Humoral Immunogenicity (NCT05076227) | Serge Thal | 2021-01-30 |
Track Serge Thal automatically
Every clearance here is in the API, with alerts when new ones post.